Analysts Set Immunic, Inc. (NASDAQ:IMUX) Price Target at $12.67
Shares of Immunic, Inc. (NASDAQ:IMUX – Get Free Report) have received an average rating of “Buy” from the eight analysts that are currently covering the company, Marketbeat reports. Six research analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 1 year target […]
Shares of Immunic, Inc. (NASDAQ:IMUX – Get Free Report) have received an average rating of “Buy” from the eight analysts that are currently covering the company, Marketbeat reports. Six research analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 1 year target […]
